The older names,<unk>  endocrine adenomas" and<unk>  endocrine adenomatosis" (MEA), have been replaced by the current terminology. The term<unk> s are used when two or more endocrine tumor types, known to occur as a part of one of the defined<unk>  syndromes, occurs in a single patient and there is evidence for either a causative mutation or hereditary transmission. The presence of two or more tumor types in a single patient does not automatically designate that individual as having<unk>  because there is a small statistical chance that the development of two "sporadic" tumors that occur in one of the<unk>  syndromes could occur by chance. The term<unk> " was introduced in 1968, but descriptions of the condition date back to 1903.
Multiple endocrine neoplasia
Late onset congenital adrenal hyperplasia
Autoimmune polyendocrine syndrome type 1
Autoimmune polyendocrine syndrome
Autoimmune polyendocrine syndrome type 2
Autoimmune polyendocrine syndrome type 3
Autoimmune thyroiditis
Primary pigmented nodular adrenocortical disease